Investors in life science


Leadership in life science investing

Working out of Copenhagen, with affiliates in San Francisco and Boston, Novo Holdings is a world-leading life science investor with a focus on creating long-term value.

Our mission is to be a supportive owner of the Novo Group companies and to make a growing and positive impact on health, science and society by generating attractive long-term returns on the assets of the Novo Nordisk Foundation.

Holdings and investments

We are the holding company of the Novo Group and manage the wealth of the Novo Nordisk Foundation. We invest in life science companies at all stages of development and in a broad portfolio of equity and fixed income securities. For more information, download our fact sheet.

Our people embrace a culture of high performance with high responsibility

Novo Holdings employs investment and business professionals focused on delivering attractive returns for the benefit of the Novo Nordisk Foundation.

Annual review

Selected key figures

  • 55 bn

    Total assets of Novo Holdings at the end of 2019.

  • 13 %

    Return on Life Science investments (IRR) last 5 years.

  • 8 %

    Return on Financial investments (IRR) last 5 years.

Novo Holdings A/S
Tuborg Havnevej 19
2900 Hellerup
+45 3527 6500
CVR# 24257630

Novo Ventures (US) Inc.*
200 Clarendon Street, Floor 45
Boston, MA 02116

Novo Ventures (US) Inc.*
501 2nd Street, Suite 300
San Francisco, CA 94107
+1 (415) 552-6686

Media Relations
Christian Mostrup Scheel
Senior Press Officer
+45 3067 4805

*Novo Ventures (US) Inc. is a separate legal entity that provides certain consultancy services to Novo Holdings A/S, mainly within the areas of identifying, analysing and negotiating various investment opportunities among life science and biotech companies in the US as well as certain follow-up activities related thereto, such as board memberships, financial control and reporting efforts.